StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Cash Payments for Restructuring During the Year by Year

Cash Payments for Restructuring During the Year ($M)

Novartis Cash Payments for Restructuring During the Year: $403M in FY2025, down 21.6% from a year earlier.

Latest, FY2025
403
Period ended Dec 31, 2025
Change on a year earlier
-21.6%
514 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Reported in Form 20-F.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCash Payments for Restructuring During the Year ($M)Year on yearSource
FY2025Dec 31, 2025403-21.6%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 2024514-37.0%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 2023816+93.8%Novartis Form 20-F (0001114448-26-000004) ↗
FY2022Dec 31, 2022421+62.5%Novartis Form 20-F (0001370368-25-000004) ↗
FY2021Dec 31, 2021259-3.4%Novartis Form 20-F (0001370368-24-000004) ↗
FY2020Dec 31, 2020268-44.1%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2019Dec 31, 2019479+230.3%Novartis Form 20-F (0001370368-22-000010) ↗
FY2018Dec 31, 2018145-27.5%Novartis Form 20-F (0001370368-21-000006) ↗
FY2017Dec 31, 2017200-23.1%Novartis Form 20-F (0001370368-20-000003) ↗
FY2016Dec 31, 2016260–Novartis Form 20-F (0001370368-19-000002) ↗

Cite this data

StockData. (2026). Novartis Cash Payments for Restructuring During the Year ($M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/prov-restructuring-used

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.